Updated Jul 16, 2026
Semba Charles Pauling has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Based on the SEC filing context for DiaMedica Therapeutics Inc. as of 2026-06-03, Semba Charles Pauling appears as an insider for the company. Publicly available biographical information is sparse, and there is no widely documented profile detailing his education, career history, or notable achievements. The available data identify him in connection with DiaMedica Therapeutics Inc., but do not specify an exact title or role (e.g., director, officer). There is no verified information indicating death or obsolescence; no obituary or public death record has been linked to this individual in relation to the 2026 filing. Given the limited public biographical data, the entry relies on the SEC filing context rather than a corroborated public biography.
| Role | Insider |
|---|---|
| Notability | 40/100 |
Based on the SEC filing context for DiaMedica Therapeutics Inc. as of 2026-06-03, Semba Charles Pauling appears as an insider for the company. Publicly available biographical information is sparse, and there is no widely documented profile detailing his education, career history, or notable achievements. The available data identify him in connection with DiaMedica Therapeutics …
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Semba Charles Pauling profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.